During the past decade, Memorial Sloan Kettering Monmouth conducted 430 clinical trials. In the 10-year time frame, 430 clinical trials started and 35 clinical trials were completed, i.e. on average, 8.1% percent of trials that started reached the finish line to date. In the past 5 years, 217 clinical trials started and 34 clinical trials were completed. i.e. 15.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Sloan Kettering Monmouth" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 360 trials, followed by "National Cancer Institute (NCI)" with 44 trials sponsored, "NRG Oncology" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored and "Pfizer" with 11 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Monmouth" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "Merck Sharp & Dohme LLC" with 15 trials as a collaborator, "Bristol-Myers Squibb" with 13 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator and "Genentech, Inc." with 12 trials as a collaborator. Other collaborators include 317 different institutions and companies that were collaborators in the rest 193 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Monmouth" are "Breast Cancer" (46 trials), "Multiple Myeloma" (19 trials), "Prostate Cancer" (18 trials), "Lung Cancer" (15 trials) and "Head and Neck Cancer" (12 trials). Many other conditions were trialed in "Memorial Sloan Kettering Monmouth" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Monmouth" are "Drug" (320 trials), "Other" (113 trials), "Radiation" (102 trials), "Procedure" (82 trials) and "Behavioral" (48 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (31 trials), "Pembrolizumab" (29 trials), "Quality-of-Life Assessment" (29 trials), "Questionnaire Administration" (23 trials) and "Cisplatin" (22 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Monmouth" are 371 trials for "All" genders, 84 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Monmouth". undefined are not yet recruiting, 224 are recruiting, 180 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Memorial Sloan Kettering Monmouth, 2 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Monmouth, 99 "Phase 1" clinical trials were conducted, 237 "Phase 2" clinical trials and 71 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 42 trials that are defined as “Not Applicable".